MARKET

DERM

DERM

Journey Medical Corp
NASDAQ
3.480
-0.100
-2.79%
After Hours: 3.400 -0.08 -2.30% 19:03 04/19 EDT
OPEN
3.510
PREV CLOSE
3.580
HIGH
3.640
LOW
3.400
VOLUME
102.50K
TURNOVER
0
52 WEEK HIGH
8.11
52 WEEK LOW
1.020
MARKET CAP
69.36M
P/E (TTM)
-16.4695
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at DERM last week (0408-0412)?
Weekly Report · 4d ago
Weekly Report: what happened at DERM last week (0401-0405)?
Weekly Report · 04/08 10:31
Weekly Report: what happened at DERM last week (0325-0329)?
Weekly Report · 04/01 10:30
Journey Medical And 2 Other Stocks Under $4 Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Retractable Technologies, Inc. President and CEO acquired a total of 5,096 shares an average price of $1.18. The Dow Jones index closed higher by over 475 points on Wednesday.
Benzinga · 03/28 11:14
VERI, CHEK and MESO are among pre market gainers
VERI, CHEK and MESO are among pre market gainers. Mesoblast (MESO) and Cazoo Group (CZOO) are among the biggest pre market losers. Krispy Kreme and AirNet Technology are also on the move.
Seeking Alpha · 03/27 12:24
Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Westport Fuel Systems Inc. (NASDAQ:WPRT) posts wider-than-expected fourth-quarter loss. Krispy Kreme, Inc. And McDonald's expanded their partnership. Stoke Therapeutics, Inc., shares gained 72.6% to $11.24. C3is Inc. Reported a year-over-year increase in financial results.
Benzinga · 03/26 17:45
12 Health Care Stocks Moving In Tuesday's Intraday Session
Stoke Therapeutics (NASDAQ:STOK) stock moved upwards by 71.8% to $11.16 during Tuesday's regular session. The company's, Q4 earnings came out 3 days ago. Mesoblast and OpGen shares also moved upwards.
Benzinga · 03/26 17:31
Weekly Report: what happened at DERM last week (0318-0322)?
Weekly Report · 03/25 10:32
More
About DERM
Journey Medical Corporation is a commercial-stage pharmaceutical company. The Company is focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its portfolio includes seven branded and two authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Its marketed products, which have been approved by the United States Food and Drug Administration (FDA) for sale, include Qbrexza, Accutane, Amzeeq, Zilxi, Exelderm Cream and Solution, Targadox and Luxamend. It sells two authorized generic products, including sulconazole nitrate cream and solution and doxycycline hyclate immediate release 50mg tablets. Qbrexza is a medicated cloth towelette for the treatment of primary axillary hyperhidrosis. Accutane is an oral isotretinoin drug for the treatment of severe recalcitrant nodular acne. Targadox is an oral doxycycline drug for adjunctive therapy for severe acne.

Webull offers Journey Medical Corp stock information, including NASDAQ: DERM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DERM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DERM stock methods without spending real money on the virtual paper trading platform.